AI-generated summary
The authors studied C2C12 myoblasts treated with lipopolysaccharide (LPS) and then exposed to photobiomodulation at 780 nm using different power and energy settings. They report that LPS increased cell viability relative to controls, that the higher power setting reduced viability, and that the treatment modulated nitric oxide synthesis but did not alter IL-6 expression. This was a cell culture study, so findings may not translate directly to living tissue.
- Who or what was studied
- C2C12 myoblast cell cultures treated with lipopolysaccharide
- Wavelengths
- 780 nm
- Limits stated in the abstract
- The study was conducted in cultured cells rather than humans or animals, so the authors' suggestion of a possible treatment for infection-related muscle injury is speculative.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 nm
- Energy density (fluence)
- 20 J/cm2
- Power
- 40 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Power output, Control group, Nitric oxide, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.